Would you like to explore ways to better manage your Alzheimer’s-related symptoms?

A study currently underway at our clinic may offer you this opportunity, and we are actively looking for participants.

All our services are confidential and offered at no cost. You do not need a referral from your doctor to visit us.

    Contact Form

    I am filling out this form for:*

    Your Information:

    First Name:* Last Name:* Phone Number:*
    Email:*
     Relationship to the person for whom the application is being completed:*
    First Name:*
     Last Name (at birth):*

    Gender:*

    Please specify:*

    Date of birth:*

    Street Address:*

    Phone Number:*
     Email:*

    Are you currently taking any medication for Alzheimer’s disease?:*

    Please specify:*

    Which clinic would you like to be contacted by?:*

    How did you hear about us?:*

    Please specify:*

    I would like my email address to be added to the mailing list:

    What is the study about?

    This phase 2 double blind study aims to evaluate whether combining MK-1167 (the investigational medication) with acetylcholinesterase inhibitor (AChEI) therapy can help improve the symptoms of Alzheimer’s Disease.

    AChEI : Aricept/Donepezil, Razadyne/Galantamine, Exelon/Rivastigmine, Namenda/Memantine

    To learn more: Study Details | A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer’s Disease Dementia (MK-1167-008) | ClinicalTrials.gov

    Why participate?

    You are already taking medication to help manage your Alzheimer’s symptoms and are interested in participating in a research program to further improve symptom management.

    To learn more: A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer’s Disease Dementia – Merck Clinical Trials

    1. Ages 55 to 90 years old

    2. Diagnosed with mild to moderate Alzheimer’s Disease

    3. On AChEI (Aricept/ Donepezil, Razadyne/Galantamine, Exelon/Rivastigmine) therapy for symptom management in Alzheimer’s Disease 

    4. English or French-speaking

    5. Must have a study partner (a close friend or family member you have frequent contact with who can attend study visits with you)

    Eligibility criteria

    Procedure

    How our clinics work | The Memory Clinic | Ottawa – Montreal

    1

    Initial Assessment

    • Medical Questionnaire and Medication Review
    • Memory Concerns and Other Cognitive Changes
    • Memory Assessments

    2

    Consent

    • The clinical research program will be presented to you in detail.
    • You will have the opportunity to ask any questions and speak with a doctor.
    • You will be given consent forms to read at home and discuss with your partner.

    3

    Screening

    Before starting the study visits, we will need to conduct preliminary tests to confirm your eligibility.

    • General health assessment with the doctor
    • Blood test to check for biomarkers
    • Cognitive evaluations
    • Brain imaging
    • Other tests

    4

    Study visits

    text test

    Testimonials

    more testimonials

    Very caring, courteous, & professional staff. They took care of my family from the moment we walked in. 
    The aftercare & our follow-up is great & I would highly recommend the clinic to any family dealing with memory/Alzheimer’s issues. 

    From my first contact with Kristina to meeting Dr. Bergeron and Dr. Moreau later on, the compassion demonstrated by them sets this clinic apart from the rest. You are not received as just a patient, but rather as someone’s parent, sibling, or often grandparent…

    Knowing your risk can help you take proactive steps to maintain cognitive health, such as making lifestyle changes, participating in clinical trials, and exploring treatment options. Don’t wait until symptoms appear; educate yourself with the latest progress and available early detection and take control of your health today.